- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05038579
Clinical Validation of a Cognitive Stimulation Platform for Individuals With Dementia - Musiquence
Dementia is a neurodegenerative syndrome that leads to cognitive deficits and, consequently, affects functionality and quality of life.
This study will explore the clinical impact of a customized cognitive stimulation program, using Musiquence.
Study Overview
Detailed Description
Dementia is a clinical syndrome characterized by a progressive and irreversible deterioration of cognitive functioning that impairs behavioral and functional domains. Within non-pharmacological approaches, Cognitive Stimulation Therapy (CST) is the most studied and well-established intervention for individuals with mild to moderate dementia. The underlying assumptions behind cognitive-based interventions of CST are:
- IwD can benefit from cognitive stimulation if mobilized relatively preserved cognitive functions (e.g., crystallized abilities such as semantic memory and verbal skills), and;
- Even in advanced age, exposure to enriched environments (i.e., socially and cognitively challenging) can enhance cognitive reserve and neuroplasticity.
Concerning the first assumption of cognitive-based interventions (a1), it is known that even in moderate to advanced stages of dementia, musical memory is one of the abilities that remain intact. It is hypothesized that music processing abilities precede the development of lexical language functions. This hypothesis is corroborated by findings that demonstrate that IwD are still responsive to music even when unable to communicate verbally or recognize words. Additionally, music is frequently associated with life experiences. Also, literature has reported that memories associated with specific music would be recollected longer than memories with no association to music; this suggests that using music as a reminiscence element on cognitive stimulation programs can have a promising effect on cognition. According to the second assumption of CST (a2), facilitating an enriching environment for IwD using, for , music and reminiscence elements could impact cognitive reserve and neuroplasticity.
In this context, Ferreira et al. developed a platform - Musiquence - that incorporates music and reminiscence in cognitive stimulation activities for IwD. Musiquence allows the gamification and personalization of 6 types of activities:
- Reality Orientation - a quiz-like activity that includes date and time information.
- Creative Drawings - a puzzle-like game in which the participant draws the missing pieces.
- Activities of Daily Living (ADL) - a puzzle-like game in which the participants have to perform a set of chores (i.e., brush the teeth), and the missing pieces are completed with real physical objects (i.e., toothpaste).
- Search Objects activity - exploration game in which the participants must find hidden images (e.g., cats) that are only visible through a virtual magnifying glass.
- Knowledge Quiz - participants must select the correct answer to a question among incorrect ones.
- Association activity - participants must categorize the items according to the instructions. For example, separate cars from motorcycles and locate them in the correct container.
The platform is compatible with different technologies that allow adaptation to the patients' needs (motor difficulties, vision problems, tremble). Cognitive stimulation content can be personalized to the user since the caregivers can add text, images, and music when creating the tasks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Autonomous Region Of Madeira
-
Funchal, Autonomous Region Of Madeira, Portugal, 9020-105
- Universidade da Madeira
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Mild to moderate stage of dementia (with formal diagnosis);
- Ability to move upper limbs;
- Maintained auditory acuity;
- Relatively preserved language skills.
Exclusion Criteria:
- Moderate to severe depressive symptomatology;
- Moderate to severe anxious symptomatology;
- Bedridden.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Musiquence
Dementia group was involved in a 14-session customized cognitive stimulation program, using Musiquence.
|
The participants performed a customized cognitive stimulation program, that was implemented in an augmented reality format, using Musiquence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mini-Mental State Examination (Cognitive Screening) (MMSE)
Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Change from baseline in the MMSE.
Minimum of 0 points and maximum of 30 points.
Higher scores mean better outcomes.
|
Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
|
Alzheimer's Disease Assessment Scale - Cognitive Scale (ADAS - Cog)
Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Change from baseline in the ADAS-Cog.
Minimum of 0 points and maximum of 68 points.
Higher scores mean worse outcomes.
|
Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life - Alzheimer's Disease (QoL - AD)
Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Change from baseline in the QoL - AD. Minimum of 0 points and maximum of 52 points.
Higher scores mean better outcomes.
|
Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
|
Kettler Laurent Thierreau (KLT)
Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Change from baseline in the KLT.
Minimum of 0 points and maximum of 100 ponints.Higher scores mean worse outcomes.
|
Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
|
Symbol Search - Weschler Adult Inteligence Scale 3rd edition (SR)
Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Change from baseline in the SR Minimum of 0 points and maximum of 10 points.. Higher scores mean better outcomes.
|
Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
|
Digital Symbol Coding - Weschler Adult Inteligence Scale 3rd edition (DSC)
Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Change from baseline in the DSC.
Minimum of 0 points and maximum of 10 points.
Higher scores mean better outcomes.
|
Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
|
Semantic and Phonemic Verbal Fluency (SPVF)
Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Change from baseline in the SPVF.
Minimum of 0 points and no maximum.
Higher scores mean better outcomes.
|
Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
|
Adults and Older Adults Functional Assessment Inventory (IAFAI)
Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Change from baseline in the IAFAI.
Minimum of 0 points and maximum of 100 points.
Higher scores mean worse outcomes.
|
Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
|
Cornell Scale for Depression in Dementia
Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Change from baseline in the Cornell Scale for Depression in Dementia.
Minimum of 0 points and maximum of 38 points.
Higher scores mean worse outcomes.
|
Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
|
Rating Anxiety in Dementia (RAID) scale.
Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Change from baseline in the RAID.
Minimum of 0 points and maximum of 54 points.
Higher scores mean worse outcomes.
|
Baseline, Post-intervention (7 weeks), Follow-up (3 months)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9/CEUMA/2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
NYU Langone HealthRecruiting
-
The University of Hong KongNot yet recruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan